KRC-01
Locally Advanced Cervical Cancer
Phase 1/2Active - First patient enrolled March 2026
Key Facts
About KORTUC
KORTUC develops hydrogen peroxide-based radiosensitizers to eliminate tumor hypoxia and make radiotherapy more effective against solid cancers.
View full company profileAbout KORTUC
KORTUC develops hydrogen peroxide-based radiosensitizers to eliminate tumor hypoxia and make radiotherapy more effective against solid cancers.
View full company profileTherapeutic Areas
Other Locally Advanced Cervical Cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| PDS0101 | PDS Biotechnology | Phase 2 |